Article

Reply to: Graefe-Mody U, Friedrich C, Port A et al. Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin. Diabetes Obes Metab 2011; 13: 939-946

Diabetes, Obesity and Metabolism
DOI: 10.1111/j.1463-1326.2012.01588.x
0Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Snyder, B., Polasek, T. M., & Doogue, M. P. (2012). Reply to: Graefe-Mody U, Friedrich C, Port A et al. Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin. Diabetes Obes Metab 2011; 13: 939-946. Diabetes, Obesity and Metabolism. Blackwell Publishing Ltd. https://doi.org/10.1111/j.1463-1326.2012.01588.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free